Early Antiplatelet for Minor Stroke Following Thrombolysis (EAST)

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1022 participants.

Also called NCT05193071

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 1,022 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05193071
Other papers using this trial's data
  • Diabetes Mellitus and Early Antiplatelet Treatment for Minor Stroke Following Intravenous Thrombolysis: Prespecified Secondary Analysis of the EAST Trial Diabetes, obesity & metabolism, 2026-07 DOI, PubMed 41944218

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05193071. Randomized; quadruple masking; primary purpose treatment. Start 2022-07-08 (actual); primary completion 2024-10-25 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Early Antiplatelet for Minor Stroke Following Thrombolysis (EAST)
Intervention (Drug)
Aspirin 100mg; Clopidogrel 300mg
Lead sponsor
General Hospital of Shenyang Military Region (class: other)

Record details

Record id
cardio:ct-nct05193071
Content hash
71400ee830a780c909d13e17687e8caa4153187409c5317ce6d1ed906371c1b3